| Title |
Detection of P. aeruginosa harboring blaCTX-M-2, blaGES-1 and blaGES-5,blaIMP-1 and blaSPM-1causing infections in Brazilian tertiary-care hospital
|
|---|---|
| Published in |
BMC Infectious Diseases, August 2012
|
| DOI | 10.1186/1471-2334-12-176 |
| Pubmed ID | |
| Authors |
Milena Polotto, Tiago Casella, Maria Gabriela de Lucca Oliveira, Fernando G Rúbio, Mauricio L Nogueira, Margarete TG de Almeida, Mara CL Nogueira |
| Abstract |
Nosocomial infections caused by Pseudomonas aeruginosa presenting resistance to beta-lactam drugs are one of the most challenging targets for antimicrobial therapy, leading to substantial increase in mortality rates in hospitals worldwide. In this context, P. aeruginosa harboring acquired mechanisms of resistance, such as production of metallo-beta-lactamase (MBLs) and extended-spectrum beta-lactamases (ESBLs) have the highest clinical impact. Hence, this study was designed to investigate the presence of genes codifying for MBLs and ESBLs among carbapenem resistant P. aeruginosa isolated in a Brazilian 720-bed teaching tertiary care hospital. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Nigeria | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 104 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 23% |
| Researcher | 17 | 16% |
| Student > Bachelor | 13 | 12% |
| Student > Ph. D. Student | 13 | 12% |
| Student > Doctoral Student | 10 | 9% |
| Other | 15 | 14% |
| Unknown | 14 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 22 | 21% |
| Agricultural and Biological Sciences | 21 | 20% |
| Immunology and Microbiology | 18 | 17% |
| Medicine and Dentistry | 14 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Other | 11 | 10% |
| Unknown | 16 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2012.
All research outputs
#18,312,024
of 22,673,450 outputs
Outputs from BMC Infectious Diseases
#5,557
of 7,641 outputs
Outputs of similar age
#126,183
of 164,731 outputs
Outputs of similar age from BMC Infectious Diseases
#58
of 84 outputs
Altmetric has tracked 22,673,450 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,641 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,731 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.